Literature DB >> 28573249

HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.

Sema Koçaşlı1, Zehra Demircan1.   

Abstract

BACKGROUND: The aim of this study was to evaluate of the use of herbal products in patients in both pre- and post- surgery periods and during chemotherapy, and to determine the factors behind it.
MATERIALS AND METHODS: This study was conducted as a descriptive study with 281 patients in 4 centers. The data of the study were collected by using a survey form prepared by the researcher, depending on literature and interview with the participants face-to-face.
RESULTS: While the average age of the patients involved in the study is 49.1±12.8, 51.6% of them were females, 34.6% graduate of elementary school, and 34.5% were housewives. While the prevelance of the use of herbal product prior to surgical treatment is 38.9%, it was observed that this rate increased to 54.1% during chemotherapy. It was observed that the most frequently used product was garlic prior to surgical treatment (19.2%), that it was urtica dioica (13.8%) during chemotherapy. Before the surgical treatment, 94.3% of the patients, and during chemotherapy treatment, 81.7% of the patients, stated that the use of herbal product had not been questioned by the physician or nurse.
CONCLUSION: Analysis of the results indicates that health professionals need to obtain information regarding the use of herbal products by cancer patients during both pre- and post- surgery periods, as well as during chemotherapy. Patients should be provided with information and guidance about the advantages and disadvantages of using herbal products.

Entities:  

Keywords:  Cancer; Drug Interaction; Herbal Product; Nursing; Phytotherapy

Mesh:

Substances:

Year:  2017        PMID: 28573249      PMCID: PMC5446458          DOI: 10.21010/ajtcam.v14i2.34

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  21 in total

Review 1.  Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening.

Authors:  Nagi B Kumar; Kathy Allen; Heather Bell
Journal:  Cancer Control       Date:  2005-07       Impact factor: 3.302

2.  Phytotherapic compounds: the consumer-pharmacist relationship.

Authors:  Marco Bacchini; Laura Cuzzolin; Thomas Camerlengo; Giampaolo Velo; Giuseppina Benoni
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

Authors:  J Barnes; S Y Mills; N C Abbot; M Willoughby; E Ernst
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Nationwide survey on complementary and alternative medicine in cancer patients in Japan.

Authors:  Ichinosuke Hyodo; Noriko Amano; Kenji Eguchi; Masaru Narabayashi; Jiro Imanishi; Midori Hirai; Tomohito Nakano; Shigemitsu Takashima
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

5.  The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

Authors:  Faruk Tas; Zeki Ustuner; Gulbeyaz Can; Yesim Eralp; Hakan Camlica; Mert Basaran; Hakan Karagol; Burak Sakar; Rian Disci; Erkan Topuz
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

6.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

8.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10

9.  Complementary and alternative medicine usage in cancer patients in southeast of Turkey.

Authors:  Mehmet Kucukoner; Zulfikar Bilge; Abdurrahman Isıkdogan; M Ali Kaplan; Ali Inal; Zuhat Urakci
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

Review 10.  Safety and efficacy of herbal sedatives in cancer care.

Authors:  Keith I Block; Charlotte Gyllenhaal; Mark N Mead
Journal:  Integr Cancer Ther       Date:  2004-06       Impact factor: 3.279

View more
  3 in total

1.  Pharmacokinetic Herb-Drug Interactions of Xiang-Sha-Liu-Jun-Zi-Tang and Paclitaxel in Male Sprague Dawley Rats and Its Influence on Enzyme Kinetics in Human Liver Microsomes.

Authors:  Alinafe Magret Kapelemera; Yow-Shieng Uang; Li-Hsuan Wang; Tien-Yuan Wu; Fang-Yu Lee; Li Tai; Ching-Chiung Wang; Chia-Jung Lee
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

Review 2.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

3.  Modulation of cancer signalling pathway(s) in two -stage mouse skin tumorigenesis by annonacin.

Authors:  Mohd Rohaizad Md Roduan; Roslida Abd Hamid; Norhafizah Mohtarrudin
Journal:  BMC Complement Altern Med       Date:  2019-09-03       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.